Study Evaluating IMA-638 in Asthma

Completed · Phase 1

Conditions studied: Asthma

In brief

The purpose of this study is to evaluate the safety of, and blood drug levels for, single, ascending doses of IMA-638 in mild to moderate asthma subjects.

Key facts

Study ID

NCT00339872

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

Starts

2006-02-01

Expected to finish

2007-04-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women of non-childbearing potential with mild to moderate asthma as defined by forced expiratory volume in 1 second (FEV1) greater than 70% predicted.
• Well controlled asthma, as exhibited by completion of asthma questionnaire.
• Otherwise healthy, except for asthma.

Where it is running

• Study site — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.